Poly Medicure Ltd. recorded a substantial block trade on the National Stock Exchange (NSE), marking significant institutional activity in the healthcare sector. The transaction represents one of the notable block deals executed in the mid-cap healthcare space.

Block Trade Details

The NSE block trade involved substantial volume and value, demonstrating significant institutional participation in the company's stock.

Market Significance

Block trades typically involve large institutional investors and represent significant market transactions. The execution of approximately 953,661 shares at ₹1,648.20 per share indicates substantial institutional interest in Poly Medicure's stock. Such transactions are often conducted by institutional investors, mutual funds, or other large market participants seeking to execute substantial volumes without impacting regular market trading.

Company Profile

Poly Medicure operates in the healthcare sector and is classified as a mid-cap stock. The company's stock trades on both major Indian exchanges, with the recent block trade highlighting continued institutional engagement with the healthcare sector.

The block trade execution at ₹1,648.20 per share provides insight into the institutional valuation of the company's stock and reflects the ongoing market dynamics in the healthcare sector.

Poly Medicure Limited has issued a clarification to BSE Limited regarding the significant increase in trading volume of its securities across exchanges in recent times. The response came following an inquiry from BSE dated January 7, 2026, seeking explanation for the unusual volume movement.

Company's Response to Volume Inquiry

The healthcare company categorically stated that there is no information or announcement, including any impending announcement, that could have a bearing on the price or volume behavior of the company's scrip as traded across exchanges. The company emphasized that such information, if it existed, would be required to be disclosed to stock exchanges under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Market-Driven Movement

Poly Medicure Limited attributed the volume movement in its securities to purely market conditions, describing it as "absolutely market driven." The company's management made it clear that the trading activity was not influenced by any internal developments or undisclosed information that would typically trigger such movements.

Regulatory Compliance Confirmation

The company reaffirmed its commitment to regulatory compliance, stating that it has been regularly disseminating unpublished price sensitive information as and when required. This disclosure practice follows the guidelines of:

• SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
• SEBI (Prohibition of Insider Trading) Regulations, 2015

The clarification was signed by Avinash Chandra, Company Secretary (Membership No: A32270), and submitted to BSE Limited at P J Towers, Dalal Street, Mumbai. The company expressed confidence that the response adequately addressed BSE's query regarding the volume movement.